Author

Fiona Sherman

NYU Langone HealthORCID 0009-0000-3846-6111Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Kwok‐Kin WongiD· 2 shared Alfonso LopeziD· 1 shared Andre Luis MoreiraiD· 1 shared Andrew J. AguirreiD· 1 shared Ayushi S. PateliD· 1 shared Benjamin G. NeeliD· 1 shared Dong GaoiD· 1 shared Eejung KimiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kwok‐Kin WongORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer Biologynpj Precision OncologyPeer-reviewedAug 20, 2025

Deep Mutational Scanning Reveals EGFR Mutations Conferring Resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945

Yueyang Wang, Yuan Hao, Michela Ranieri…·John Thomas Poirier

This study identifies EGFR mutations conferring resistance to BLU-945 using deep mutational scanning and shows that combination treatment may suppress resistance mechanisms.

4 citations

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyCancer CellPeer-reviewedFeb 22, 2024

Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer

Xinyuan Tong, Ayushi S. Patel, Eejung Kim…·Hongbin Ji

The paper identifies adeno-to-squamous transition (AST) as a mechanism of resistance to KRAS inhibitors in LKB1 mutant lung cancer and links KRT6A expression to poor patient outcomes.

149 citationstop 1%

mousebulk RNA-seq

𝕏 PostBluesky